Investigational Drug Information for Ritanserin
✉ Email this page to a colleague
What is the development status for investigational drug Ritanserin?
Ritanserin is an investigational drug.
There have been 3 clinical trials for Ritanserin.
The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 1992.
The most common disease conditions in clinical trials are Panic Disorder, Depressive Disorder, Major, and Depression. The leading clinical trial sponsors are Beth Israel Medical Center, National Institute on Drug Abuse (NIDA), and University of Pennsylvania.
Summary for Ritanserin
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 2,032 |
WIPO Patent Applications | 853 |
Japanese Patent Applications | 305 |
Clinical Trial Progress | Phase 2 (1992-07-01) |
Vendors | 0 |
Recent Clinical Trials for Ritanserin
Title | Sponsor | Phase |
---|---|---|
Risperidone vs. Paroxetine for Panic Attacks | Beth Israel Medical Center | Phase 2 |
A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks | Beth Israel Medical Center | N/A |
Ritanserin in Treatment of Cocaine Dependence - 1 | National Institute on Drug Abuse (NIDA) | Phase 2 |
Clinical Trial Summary for Ritanserin
Top disease conditions for Ritanserin
Top clinical trial sponsors for Ritanserin
US Patents for Ritanserin
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |